{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T09:01:02Z","timestamp":1781168462554,"version":"3.54.1"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T00:00:00Z","timestamp":1641859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T00:00:00Z","timestamp":1641859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["L30 AR076081"],"award-info":[{"award-number":["L30 AR076081"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["K23 AR075888"],"award-info":[{"award-number":["K23 AR075888"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["K23 AR075888"],"award-info":[{"award-number":["K23 AR075888"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s40257-021-00665-w","type":"journal-article","created":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T19:18:44Z","timestamp":1641928724000},"page":"219-229","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Treating Acne in Transgender Persons Receiving Testosterone: A Practical Guide"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7539-0224","authenticated-orcid":false,"given":"Rakan","family":"Radi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5907-6937","authenticated-orcid":false,"given":"Sarah","family":"Gold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6299-3982","authenticated-orcid":false,"given":"Juan P.","family":"Acosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1358-5151","authenticated-orcid":false,"given":"Jason","family":"Barron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4815-4936","authenticated-orcid":false,"given":"Howa","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,11]]},"reference":[{"issue":"Suppl 1","key":"665_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/bjd.13462","volume":"172","author":"JK Tan","year":"2015","unstructured":"Tan JK, Bhate K. A global perspective on the epidemiology of acne. Br J Dermatol. 2015;172(Suppl 1):3\u201312.","journal-title":"Br J Dermatol"},{"issue":"5","key":"665_CR2","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1001\/jamadermatol.2016.5538","volume":"153","author":"C Karimkhani","year":"2017","unstructured":"Karimkhani C, Dellavalle RP, Coffeng LE, Flohr C, Hay RJ, Langan SM, et al. Global skin disease morbidity and mortality: an update from the global burden of disease study 2013. JAMA Dermatol. 2017;153(5):406\u201312.","journal-title":"JAMA Dermatol"},{"key":"665_CR3","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2147\/CCID.S114830","volume":"9","author":"ML Elsaie","year":"2016","unstructured":"Elsaie ML. Hormonal treatment of acne vulgaris: an update. Clin Cosmet Investig Dermatol. 2016;9:241\u20138.","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"2","key":"665_CR4","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.ecl.2019.01.005","volume":"48","author":"H Yeung","year":"2019","unstructured":"Yeung H, Kahn B, Ly BC, Tangpricha V. Dermatologic conditions in transgender populations. Endocrinol Metab Clin North Am. 2019;48(2):429\u201340.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"1a","key":"665_CR5","doi-asserted-by":"publisher","first-page":"89s","DOI":"10.1016\/S0002-9343(99)80064-3","volume":"98","author":"AW Lucky","year":"1995","unstructured":"Lucky AW. Hormonal correlates of acne and hirsutism. Am J Med. 1995;98(1a):89s\u201394s.","journal-title":"Am J Med"},{"issue":"2","key":"665_CR6","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/j.1610-0387.2007.06176.x","volume":"5","author":"B Melnik","year":"2007","unstructured":"Melnik B, Jansen T, Grabbe S. Abuse of anabolic-androgenic steroids and bodybuilding acne: an underestimated health problem. J Dtsch Dermatol Ges. 2007;5(2):110\u20137.","journal-title":"J Dtsch Dermatol Ges"},{"issue":"2","key":"665_CR7","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.det.2019.10.006","volume":"38","author":"L Ragmanauskaite","year":"2020","unstructured":"Ragmanauskaite L, Kahn B, Ly B, Yeung H. Acne and the lesbian, gay, bisexual, or transgender teenager. Dermatol Clin. 2020;38(2):219\u201326.","journal-title":"Dermatol Clin"},{"issue":"1","key":"665_CR8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/bjd.17083","volume":"180","author":"CC Motosko","year":"2019","unstructured":"Motosko CC, Zakhem GA, Pomeranz MK, Hazen A. Acne: a side-effect of masculinizing hormonal therapy in transgender patients. Br J Dermatol. 2019;180(1):26\u201330.","journal-title":"Br J Dermatol"},{"issue":"2","key":"665_CR9","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ucl.2016.01.004","volume":"43","author":"M Khera","year":"2016","unstructured":"Khera M. Testosterone therapies. Urol Clin North Am. 2016;43(2):185\u201393.","journal-title":"Urol Clin North Am"},{"issue":"4","key":"665_CR10","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1111\/j.1743-6109.2011.02634.x","volume":"9","author":"SR Davis","year":"2012","unstructured":"Davis SR, Braunstein GD. Efficacy and safety of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women. J Sex Med. 2012;9(4):1134\u201348.","journal-title":"J Sex Med"},{"issue":"3","key":"665_CR11","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.jaad.2018.02.042","volume":"80","author":"H Yeung","year":"2019","unstructured":"Yeung H, Luk KM, Chen SC, Ginsberg BA, Katz KA. Dermatologic care for lesbian, gay, bisexual, and transgender persons: terminology, demographics, health disparities, and approaches to care. J Am Acad Dermatol. 2019;80(3):581\u20139.","journal-title":"J Am Acad Dermatol"},{"key":"665_CR12","doi-asserted-by":"crossref","unstructured":"Coleman E, Bockting W, Botzer M, Cohen-Kettenis P, DeCuypere G, Feldman J, et al. Standards of care for the health of transsexual, transgender, and gender-nonconforming people, version 7. Int J Transgend. 2012:165\u2013232.","DOI":"10.1080\/15532739.2011.700873"},{"issue":"3","key":"665_CR13","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1001\/jamadermatol.2020.5347","volume":"157","author":"N Thoreson","year":"2021","unstructured":"Thoreson N, Park JA, Grasso C, Potter J, King DS, Marc LG, et al. Incidence and factors associated with acne among transgender patients receiving masculinizing hormone therapy. JAMA Dermatol. 2021;157(3):290\u20135.","journal-title":"JAMA Dermatol"},{"issue":"1","key":"665_CR14","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/jsm.12366","volume":"11","author":"K Wierckx","year":"2014","unstructured":"Wierckx K, Van de Peer F, Verhaeghe E, Dedecker D, Van Caenegem E, Toye K, et al. Short- and long-term clinical skin effects of testosterone treatment in trans men. J Sex Med. 2014;11(1):222\u20139.","journal-title":"J Sex Med"},{"issue":"2","key":"665_CR15","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.jaad.2018.12.040","volume":"81","author":"JA Park","year":"2019","unstructured":"Park JA, Carter EE, Larson AR. Risk factors for acne development in the first 2 years after initiating masculinizing testosterone therapy among transgender men. J Am Acad Dermatol. 2019;81(2):617\u20138.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"665_CR16","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1507\/endocrj.EJ12-0319","volume":"60","author":"A Nakamura","year":"2013","unstructured":"Nakamura A, Watanabe M, Sugimoto M, Sako T, Mahmood S, Kaku H, et al. Dose-response analysis of testosterone replacement therapy in patients with female to male gender identity disorder. Endocr J. 2013;60(3):275\u201381.","journal-title":"Endocr J"},{"issue":"5","key":"665_CR17","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1016\/j.jaad.2020.02.053","volume":"83","author":"H Yeung","year":"2020","unstructured":"Yeung H, Ragmanauskaite L, Zhang Q, Kim J, Tangpricha V, Getahun D, et al. Prevalence of moderate to severe acne in transgender adults: a cross-sectional survey. J Am Acad Dermatol. 2020;83(5):1450\u20132.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"665_CR18","doi-asserted-by":"publisher","first-page":"e20200728","DOI":"10.1542\/peds.2020-0728","volume":"147","author":"SM Peitzmeier","year":"2021","unstructured":"Peitzmeier SM, Silberholz J, Gardner IH, Weinand J, Acevedo K. Time to first onset of chest binding-related symptoms in transgender youth. Pediatrics. 2021;147(3):e20200728.","journal-title":"Pediatrics"},{"issue":"5","key":"665_CR19","doi-asserted-by":"publisher","first-page":"e20173845","DOI":"10.1542\/peds.2017-3845","volume":"141","author":"TA Becerra-Culqui","year":"2018","unstructured":"Becerra-Culqui TA, Liu Y, Nash R, Cromwell L, Flanders WD, Getahun D, et al. Mental health of transgender and gender nonconforming youth compared with their peers. Pediatrics. 2018;141(5):e20173845.","journal-title":"Pediatrics"},{"issue":"9","key":"665_CR20","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.11124\/JBISRIR-2017-003869","volume":"17","author":"S Rowniak","year":"2019","unstructured":"Rowniak S, Bolt L, Sharifi C. Effect of cross-sex hormones on the quality of life, depression and anxiety of transgender individuals: a quantitative systematic review. JBI Database Syst Rev Implement Rep. 2019;17(9):1826\u201354.","journal-title":"JBI Database Syst Rev Implement Rep"},{"issue":"1","key":"665_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5070\/D34HP8N68P","volume":"17","author":"LK Dunn","year":"2011","unstructured":"Dunn LK, O\u2019Neill JL, Feldman SR. Acne in adolescents: quality of life, self-esteem, mood, and psychological disorders. Dermatol Online J. 2011;17(1):1.","journal-title":"Dermatol Online J"},{"issue":"4","key":"665_CR22","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.jsxm.2018.01.017","volume":"15","author":"AA Owen-Smith","year":"2018","unstructured":"Owen-Smith AA, Gerth J, Sineath RC, Barzilay J, Becerra-Culqui TA, Getahun D, et al. Association between gender confirmation treatments and perceived gender congruence, body image satisfaction, and mental health in a cohort of transgender individuals. J Sex Med. 2018;15(4):591\u2013600.","journal-title":"J Sex Med"},{"issue":"Suppl 2","key":"665_CR23","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/pde.14686","volume":"38","author":"I Covelli","year":"2021","unstructured":"Covelli I, Ahrens K, Onchiri FM, Inwards-Breland D, Boos MD. Influence of gender and sexual identity on adolescent skin health. Pediatr Dermatol. 2021;38(Suppl 2):65\u201372.","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"665_CR24","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1001\/jamadermatol.2020.5353","volume":"157","author":"H Braun","year":"2021","unstructured":"Braun H, Zhang Q, Getahun D, Silverberg MJ, Tangpricha V, Goodman M, et al. Moderate-to-severe acne and mental health symptoms in transmasculine persons who have received testosterone. JAMA Dermatol. 2021;157(3):344\u20136.","journal-title":"JAMA Dermatol"},{"key":"665_CR25","doi-asserted-by":"publisher","first-page":"100608","DOI":"10.1016\/j.ssmph.2020.100608","volume":"11","author":"L Kcomt","year":"2020","unstructured":"Kcomt L, Gorey KM, Barrett BJ, McCabe SE. Healthcare avoidance due to anticipated discrimination among transgender people: a call to create trans-affirmative environments. SSM Popul Health. 2020;11:100608.","journal-title":"SSM Popul Health."},{"issue":"2","key":"665_CR26","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/MED.0000000000000227","volume":"23","author":"JD Safer","year":"2016","unstructured":"Safer JD, Coleman E, Feldman J, Garofalo R, Hembree W, Radix A, et al. Barriers to healthcare for transgender individuals. Curr Opin Endocrinol Diabetes Obes. 2016;23(2):168\u201371.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"4","key":"665_CR27","doi-asserted-by":"publisher","first-page":"e20182162","DOI":"10.1542\/peds.2018-2162","volume":"142","author":"J Rafferty","year":"2018","unstructured":"Rafferty J, Committee On Psychosocial Aspects of Child and Family Health, Committee On Adolescence, Section On Lesbian Gay, Bisexual, and Transgender Health and Wellness. Ensuring comprehensive care and support for transgender and gender-diverse children and adolescents. Pediatrics. 2018;142(4):e20182162.","journal-title":"Pediatrics"},{"issue":"3","key":"665_CR28","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.jaad.2018.02.045","volume":"80","author":"H Yeung","year":"2019","unstructured":"Yeung H, Luk KM, Chen SC, Ginsberg BA, Katz KA. Dermatologic care for lesbian, gay, bisexual, and transgender persons: epidemiology, screening, and disease prevention. J Am Acad Dermatol. 2019;80(3):591\u2013602.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"665_CR29","doi-asserted-by":"publisher","first-page":"ITC1","DOI":"10.7326\/AITC201907020","volume":"171","author":"JD Safer","year":"2019","unstructured":"Safer JD, Tangpricha V. Care of the transgender patient. Ann Intern Med. 2019;171(1):ITC1\u201316.","journal-title":"Ann Intern Med"},{"issue":"8","key":"665_CR30","doi-asserted-by":"publisher","first-page":"e186506","DOI":"10.1001\/jamanetworkopen.2018.6506","volume":"1","author":"A Haider","year":"2018","unstructured":"Haider A, Adler RR, Schneider E, Uribe Leitz T, Ranjit A, Ta C, et al. Assessment of patient-centered approaches to collect sexual orientation and gender identity information in the emergency department: the EQUALITY study. JAMA Netw Open. 2018;1(8):e186506.","journal-title":"JAMA Netw Open"},{"issue":"2","key":"665_CR31","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1001\/jamadermatol.2018.3909","volume":"155","author":"MD Mansh","year":"2019","unstructured":"Mansh MD, Nguyen A, Katz KA. Improving dermatologic care for sexual and gender minority patients through routine sexual orientation and gender identity data collection. JAMA Dermatol. 2019;155(2):145\u20136.","journal-title":"JAMA Dermatol"},{"issue":"7","key":"665_CR32","first-page":"30","volume":"35","author":"L Hashemi","year":"2018","unstructured":"Hashemi L, Weinreb J, Weimer AK, Weiss RL. Transgender care in the primary care setting: a review of guidelines and literature. Fed Pract. 2018;35(7):30\u20137.","journal-title":"Fed Pract"},{"issue":"2","key":"665_CR33","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ajog.2019.07.043","volume":"222","author":"C Krempasky","year":"2020","unstructured":"Krempasky C, Harris M, Abern L, Grimstad F. Contraception across the transmasculine spectrum. Am J Obstet Gynecol. 2020;222(2):134\u201343.","journal-title":"Am J Obstet Gynecol"},{"key":"665_CR34","unstructured":"Deutsch MB. Guidelines for the primary and gender-affirming care of transgender and gender nonbinary people. 2nd edition. 2016 [cited 19 Aug 2021]. Available at: https:\/\/transcare.ucsf.edu\/guidelines."},{"issue":"3","key":"665_CR35","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1097\/DSS.0000000000001718","volume":"45","author":"DH Marks","year":"2019","unstructured":"Marks DH, Awosika O, Rengifo-Pardo M, Ehrlich A. Dermatologic surgical care for transgender individuals. Dermatol Surg. 2019;45(3):446\u201357.","journal-title":"Dermatol Surg"},{"issue":"6","key":"665_CR36","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1097\/AOG.0000000000000540","volume":"124","author":"AD Light","year":"2014","unstructured":"Light AD, Obedin-Maliver J, Sevelius JM, Kerns JL. Transgender men who experienced pregnancy after female-to-male gender transitioning. Obstet Gynecol. 2014;124(6):1120\u20137.","journal-title":"Obstet Gynecol"},{"issue":"3","key":"665_CR37","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.jaad.2016.03.042","volume":"75","author":"H Yeung","year":"2016","unstructured":"Yeung H, Chen SC, Katz KA, Stoff BK. Prescribing isotretinoin in the United States for transgender individuals: ethical considerations. J Am Acad Dermatol. 2016;75(3):648\u201351.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"665_CR38","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.jaad.2015.12.037","volume":"74","author":"AL Zaenglein","year":"2016","unstructured":"Zaenglein AL, Pathy AL, Schlosser BJ, Alikhan A, Baldwin HE, Berson DS, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945-73.e33.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"665_CR39","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1016\/j.jaad.2019.02.044","volume":"80","author":"J Tan","year":"2019","unstructured":"Tan J, Thiboutot D, Popp G, Gooderham M, Lynde C, Del Rosso J, et al. Randomized phase 3 evaluation of trifarotene 50 \u03bcg\/g cream treatment of moderate facial and truncal acne. J Am Acad Dermatol. 2019;80(6):1691\u20139.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"665_CR40","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3122\/jabfm.2016.02.150165","volume":"29","author":"AL Chien","year":"2016","unstructured":"Chien AL, Qi J, Rainer B, Sachs DL, Helfrich YR. Treatment of acne in pregnancy. J Am Board Fam Med. 2016;29(2):254\u201362.","journal-title":"J Am Board Fam Med"},{"issue":"3","key":"665_CR41","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s13555-017-0185-2","volume":"7","author":"J Leyden","year":"2017","unstructured":"Leyden J, Stein-Gold L, Weiss J. Why topical retinoids are mainstay of therapy for acne. Dermatol Ther (Heidelb). 2017;7(3):293\u2013304.","journal-title":"Dermatol Ther (Heidelb)."},{"issue":"3","key":"665_CR42","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2165\/11597880-000000000-00000","volume":"13","author":"R Gamble","year":"2012","unstructured":"Gamble R, Dunn J, Dawson A, Petersen B, McLaughlin L, Small A, et al. Topical antimicrobial treatment of acne vulgaris: an evidence-based review. Am J Clin Dermatol. 2012;13(3):141\u201352.","journal-title":"Am J Clin Dermatol"},{"issue":"5","key":"665_CR43","first-page":"412","volume":"18","author":"C Rosette","year":"2019","unstructured":"Rosette C, Agan FJ, Mazzetti A, Moro L, Gerloni M. Cortexolone 17\u03b1-propionate (clascoterone) is a novel androgen receptor antagonist that inhibits production of lipids and inflammatory cytokines from sebocytes in vitro. J Drugs Dermatol. 2019;18(5):412\u20138.","journal-title":"J Drugs Dermatol"},{"issue":"6","key":"665_CR44","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1001\/jamadermatol.2020.0465","volume":"156","author":"A Hebert","year":"2020","unstructured":"Hebert A, Thiboutot D, Stein Gold L, Cartwright M, Gerloni M, Fragasso E, et al. Efficacy and safety of topical clascoterone cream, 1%, for treatment in patients with facial acne: two phase 3 randomized clinical trials. JAMA Dermatol. 2020;156(6):621\u201330.","journal-title":"JAMA Dermatol"},{"issue":"1","key":"665_CR45","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jid.2020.05.086","volume":"141","author":"TM DeGrazia","year":"2021","unstructured":"DeGrazia TM, Rolader R, Thiboutot DM, Yeung H. Eligibility criteria related to hormone therapy in acne clinical trials: a systematic review. J Invest Dermatol. 2021;141(1):189\u201391.","journal-title":"J Invest Dermatol"},{"issue":"12","key":"665_CR46","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1001\/jamadermatol.2020.4380","volume":"156","author":"DH Marks","year":"2020","unstructured":"Marks DH, Mansh MD. Potential role for topical antiandrogens in the management of acne among patients receiving masculinizing hormone therapy. JAMA Dermatol. 2020;156(12):1380\u20131.","journal-title":"JAMA Dermatol"},{"issue":"3","key":"665_CR47","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.sder.2008.07.001","volume":"27","author":"GF Webster","year":"2008","unstructured":"Webster GF, Graber EM. Antibiotic treatment for acne vulgaris. Semin Cutan Med Surg. 2008;27(3):183\u20137.","journal-title":"Semin Cutan Med Surg"},{"issue":"5","key":"665_CR48","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.clindermatol.2004.03.014","volume":"22","author":"A Katsambas","year":"2004","unstructured":"Katsambas A, Papakonstantinou A. Acne: systemic treatment. Clin Dermatol. 2004;22(5):412\u20138.","journal-title":"Clin Dermatol"},{"issue":"8","key":"665_CR49","first-page":"CD002086","volume":"2012","author":"SE Garner","year":"2012","unstructured":"Garner SE, Eady A, Bennett C, Newton JN, Thomas K, Popescu CM. Minocycline for acne vulgaris: efficacy and safety. Cochrane Database Syst Rev. 2012;2012(8):CD002086.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"665_CR50","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1517\/14740338.2016.1133584","volume":"15","author":"R Cross","year":"2016","unstructured":"Cross R, Ling C, Day NP, McGready R, Paris DH. Revisiting doxycycline in pregnancy and early childhood\u2013time to rebuild its reputation? Expert Opin Drug Saf. 2016;15(3):367\u201382.","journal-title":"Expert Opin Drug Saf"},{"issue":"5","key":"665_CR51","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/dth.12370","volume":"29","author":"G Farrah","year":"2016","unstructured":"Farrah G, Tan E. The use of oral antibiotics in treating acne vulgaris: a new approach. Dermatol Ther. 2016;29(5):377\u201384.","journal-title":"Dermatol Ther"},{"issue":"1\u20132","key":"665_CR52","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.mce.2003.10.005","volume":"217","author":"SM Garthwaite","year":"2004","unstructured":"Garthwaite SM, McMahon EG. The evolution of aldosterone antagonists. Mol Cell Endocrinol. 2004;217(1\u20132):27\u201331.","journal-title":"Mol Cell Endocrinol"},{"issue":"2\u20133","key":"665_CR53","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1159\/000471799","volume":"233","author":"R Grandhi","year":"2017","unstructured":"Grandhi R, Alikhan A. Spironolactone for the treatment of acne: a 4-year retrospective study. Dermatology. 2017;233(2\u20133):141\u20134.","journal-title":"Dermatology"},{"issue":"8","key":"665_CR54","first-page":"475","volume":"100","author":"LK Oge","year":"2019","unstructured":"Oge LK, Broussard A, Marshall MD. Acne vulgaris: diagnosis and treatment. Am Fam Physician. 2019;100(8):475\u201384.","journal-title":"Am Fam Physician"},{"issue":"8","key":"665_CR55","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1210\/jcem.85.8.6710","volume":"85","author":"EJ Giltay","year":"2000","unstructured":"Giltay EJ, Gooren LJ. Effects of sex steroid deprivation\/administration on hair growth and skin sebum production in transsexual males and females. J Clin Endocrinol Metab. 2000;85(8):2913\u201321.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"665_CR56","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s40257-016-0245-x","volume":"18","author":"AM Layton","year":"2017","unstructured":"Layton AM, Eady EA, Whitehouse H, Del Rosso JQ, Fedorowicz Z, van Zuuren EJ. Oral spironolactone for acne vulgaris in adult females: a hybrid systematic review. Am J Clin Dermatol. 2017;18(2):169\u201391.","journal-title":"Am J Clin Dermatol"},{"issue":"8","key":"665_CR57","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.3390\/molecules21081063","volume":"21","author":"L Fox","year":"2016","unstructured":"Fox L, Csongradi C, Aucamp M, du Plessis J, Gerber M. Treatment modalities for acne. Molecules. 2016;21(8):1063.","journal-title":"Molecules"},{"issue":"1","key":"665_CR58","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1089\/trgh.2017.0021","volume":"2","author":"JM Carswell","year":"2017","unstructured":"Carswell JM, Roberts SA. Induction and maintenance of amenorrhea in transmasculine and nonbinary adolescents. Transgend Health. 2017;2(1):195\u2013201.","journal-title":"Transgend Health."},{"issue":"2","key":"665_CR59","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.jaad.2018.09.055","volume":"80","author":"JS Barbieri","year":"2019","unstructured":"Barbieri JS, Spaccarelli N, Margolis DJ, James WD. Approaches to limit systemic antibiotic use in acne: systemic alternatives, emerging topical therapies, dietary modification, and laser and light-based treatments. J Am Acad Dermatol. 2019;80(2):538\u201349.","journal-title":"J Am Acad Dermatol"},{"issue":"1 Suppl","key":"665_CR60","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1067\/mjd.2003.618","volume":"49","author":"H Gollnick","year":"2003","unstructured":"Gollnick H, Cunliffe W, Berson D, Dreno B, Finlay A, Leyden JJ, et al. Management of acne: a report from a global alliance to improve outcomes in acne. J Am Acad Dermatol. 2003;49(1 Suppl):S1-37.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"665_CR61","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1067\/mjd.2001.115965","volume":"45","author":"JS Strauss","year":"2001","unstructured":"Strauss JS, Leyden JJ, Lucky AW, Lookingbill DP, Drake LA, Hanifin JM, et al. A randomized trial of the efficacy of a new micronized formulation versus a standard formulation of isotretinoin in patients with severe recalcitrant nodular acne. J Am Acad Dermatol. 2001;45(2):187\u201395.","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"665_CR62","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1001\/jamadermatol.2015.0761","volume":"151","author":"L Turrion-Merino","year":"2015","unstructured":"Turrion-Merino L, Urech-Garcia-de-la-Vega M, Miguel-Gomez L, Harto-Castano A, Jaen-Olasolo P. Severe acne in female-to-male transgender patients. JAMA Dermatol. 2015;151(11):1260\u20131.","journal-title":"JAMA Dermatol"},{"key":"665_CR63","unstructured":"iPLEDGE. Prescriber isotretinoin educational kit. 2017. Available at: https:\/\/www.ipledgeprogram.com\/iPledgeUI\/rems\/pdf\/resources\/Prescriber%20Isotretinoin%20Educational%20Kit.pdf."},{"issue":"5","key":"665_CR64","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1001\/jamadermatol.2015.5547","volume":"152","author":"KA Katz","year":"2016","unstructured":"Katz KA. Transgender patients, isotretinoin, and US Food and Drug Administration-mandated risk evaluation and mitigation strategies: a prescription for inclusion. JAMA Dermatol. 2016;152(5):513\u20134.","journal-title":"JAMA Dermatol"},{"key":"665_CR65","unstructured":"US Food and Drug Administration. iPLEDGE risk evaluation and mitigation strategy (REMS). [cited 17 Nov 2021]. Available at: https:\/\/www.fda.gov\/drugs\/postmarket-drug-safety-information-patients-and-providers\/ipledge-risk-evaluation-and-mitigation-strategy-rems."},{"key":"665_CR66","unstructured":"iPLEDGE 2021 Prescriber information session [cited 17 Nov 2021]. Available at: https:\/\/www.ipledge.syneoshealthlearning.com\/copy-of-video-page."},{"issue":"1","key":"665_CR67","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1097\/JDN.0000000000000595","volume":"13","author":"S Kane","year":"2021","unstructured":"Kane S, Admani S. COVID-19 pandemic leading to the accelerated development of a virtual health model for isotretinoin. J Dermatol Nurses Assoc. 2021;13(1):54\u20137.","journal-title":"J Dermatol Nurses Assoc."},{"issue":"2","key":"665_CR68","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.sder.2005.04.003","volume":"24","author":"AL Marqueling","year":"2005","unstructured":"Marqueling AL, Zane LT. Depression and suicidal behavior in acne patients treated with isotretinoin: a systematic review. Semin Cutan Med Surg. 2005;24(2):92\u2013102.","journal-title":"Semin Cutan Med Surg"},{"issue":"6","key":"665_CR69","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.jaad.2016.12.028","volume":"76","author":"YC Huang","year":"2017","unstructured":"Huang YC, Cheng YC. Isotretinoin treatment for acne and risk of depression: a systematic review and meta-analysis. J Am Acad Dermatol. 2017;76(6):1068-76 e9.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"665_CR70","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.chc.2019.02.016","volume":"28","author":"B Johnson","year":"2019","unstructured":"Johnson B, Leibowitz S, Chavez A, Herbert SE. Risk versus resiliency: addressing depression in lesbian, gay, bisexual, and transgender youth. Child Adolesc Psychiatr Clin N Am. 2019;28(3):509\u201321.","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"issue":"3","key":"665_CR71","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1037\/a0031774","volume":"81","author":"SL Budge","year":"2013","unstructured":"Budge SL, Adelson JL, Howard KA. Anxiety and depression in transgender individuals: the roles of transition status, loss, social support, and coping. J Consult Clin Psychol. 2013;81(3):545\u201357.","journal-title":"J Consult Clin Psychol"},{"issue":"5","key":"665_CR72","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/ced.14194","volume":"45","author":"L Campos-Munoz","year":"2020","unstructured":"Campos-Munoz L, Lopez-De Lara D, Conde-Taboada A, Fueyo Casado A, Lopez-Bran E. Depression in transgender adolescents under treatment with isotretinoin. Clin Exp Dermatol. 2020;45(5):615\u20136.","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"665_CR73","doi-asserted-by":"publisher","first-page":"e13584","DOI":"10.1111\/dth.13584","volume":"33","author":"T Peng","year":"2020","unstructured":"Peng T, Li ZM, Liu J, Zhang Y. Evaluation of reliability and validity of the Patient Health Questionnaire-9 in patients with acne. Dermatol Ther. 2020;33(4):e13584.","journal-title":"Dermatol Ther"},{"issue":"5","key":"665_CR74","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1089\/lgbt.2019.0313","volume":"7","author":"S Singer","year":"2020","unstructured":"Singer S, Keuroghlian AS. A call for gender identity data collection in iPLEDGE and increasing the number of isotretinoin prescribers among transgender health providers. LGBT Health. 2020;7(5):216\u20139.","journal-title":"LGBT Health"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-021-00665-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40257-021-00665-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-021-00665-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T11:16:34Z","timestamp":1744715794000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40257-021-00665-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,11]]},"references-count":74,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["665"],"URL":"https:\/\/doi.org\/10.1007\/s40257-021-00665-w","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,11]]},"assertion":[{"value":"7 December 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This manuscript is supported in part by grants from the National Institute of Arthritis and Musculoskeletal and Skin Diseases L30 AR076081 (HY) and K23 AR075888 (JB, HY). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Howa Yeung received honorarium from Syneos Health and the American Academy of Dermatology. Rakan Radi, Sarah Gold, Juan Acosta, and Jason Barron have no conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"HY originated the idea for this article. All authors performed the literature search and data analysis. RR, SG, and JA drafted the manuscript and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Signed patient consent for publication of the photos in Fig.\u00a0 has been obtained.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}